The present invention relates to particulate forms of anamorelinmonohydrochlorideor a composition comprising anamorelin monohydrochloride having controlledchloridecontent, preferably isolated in an amorphous and/or fine particulate state,processes formaking the particulate forms, and pharmaceutical compositions comprising theparticulateform s.